EPHA3 and cancer: Surprisingly, however, EPHA3 was identified in early genome-wide sequencing studies in colorectal tumors14 as the sixth most frequently mutated gene with mutations in >11% of the tumors and a cancer mutation prevalence (CaMP) score >4.